Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
French Biotech Company AdipoPharma Secures Funding for Groundbreaking Diabetes Drug
AdipoPharma, a French biotech company developing a novel and promising type 2 diabetes drug, has […]
Ferronova Secures A$11 Million to Advance Nanotech Image-guided Cancer Therapy
Australian biotech company Ferronova has announced it has secured a further A$11 million to progress […]
CureLab Veterinary Launches Equity Crowdfunding Campaign on Netcapital to Revolutionize Medicine for Dogs, Cats, and Horses
CureLab Veterinary, an emerging animal health biotech company, has launched its crowdfunding campaign via Netcapital, […]
InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux
InDevR, a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has […]
Eagle Genomics Disclose Funding from OMRON Ventures to Drive Sustainability Innovation in Microbiome R&D
Today, Eagle Genomics, the pioneering TechBio platform business applying network science to biology, disclosed additional […]
Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities
Armata Pharmaceuticals, a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial […]
Alira Health Accelerates Global Growth and Secures Additional $58M in Funding
Alira Health, a global healthcare advisory, clinical research and technology company, announced it secured an […]
SoniVie Raises $60m in Round C Financing and Appoints New Board Members
SoniVie, a medical device company developing a proprietary solution to treat hypertension, announced today the […]
Amolyt Pharma Announces $138 Million Series C Financing
Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related […]
Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million
Immune-Onc Therapeutics, a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more